doi: 10.1038/s41563-022-01360-9. Epub 2022 Sep 22.
Nanoparticle-modified microrobots for in vivo antibiotic delivery to treat acute bacterial pneumonia
Affiliations
- PMID:36138145
- PMCID: PMC9633541
- DOI: 10.1038/s41563-022-01360-9
Item in Clipboard
Nanoparticle-modified microrobots for in vivo antibiotic delivery to treat acute bacterial pneumonia
Fangyu Zhang et al. Nat Mater.2022 Nov.
Display options
Format
Display options
Format
Abstract
Bioinspired microrobots capable of actively moving in biological fluids have attracted considerable attention for biomedical applications because of their unique dynamic features that are otherwise difficult to achieve by their static counterparts. Here we use click chemistry to attach antibiotic-loaded neutrophil membrane-coated polymeric nanoparticles to natural microalgae, thus creating hybrid microrobots for the active delivery of antibiotics in the lungs in vivo. The microrobots show fast speed (>110 µm s-1) in simulated lung fluid and uniform distribution into deep lung tissues, low clearance by alveolar macrophages and superb tissue retention time (>2 days) after intratracheal administration to test animals. In a mouse model of acute Pseudomonas aeruginosa pneumonia, the microrobots effectively reduce bacterial burden and substantially lessen animal mortality, with negligible toxicity. Overall, these findings highlight the attractive functions of algae-nanoparticle hybrid microrobots for the active in vivo delivery of therapeutics to the lungs in intensive care unit settings.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.
Conflict of interest statement
Competing interests
The authors declare no competing interests.
Figures
a, Schematic depicting the use of algae-NP-robot for the treatment of a bacterial lung infection.C. reinhardtii algae is modified with drug-loaded NPs and then administeredin vivo for the treatment ofP. aeruginosa lung infection. The NP is consisting of neutrophil membrane-coated poly(lactic-co-glycolic) (PLGA) core.b, Schematic of the functionalization ofC. reinhardtii with drug-loaded NP using click chemistry.c, Brightfield and fluorescent images of the NP, in which the PLGA cores are labeled with DiO (green color) and the neutrophil membranes are labeled with DiI (red color). Scale bar: 1 μm.d, Pseudocolored scanning electron microscopy images of an unmodified algae (left) and an algae-NP-robot (right). Scale bar: 2 μm.e, Flow cytometric analysis of algae before (left) and after (right) functionalization with DiO-labeled NP.f, Brightfield and fluorescent images of algae-NP-robot. Autofluorescence of natural algae chloroplast in Cy5 channel; DiO-labeled PLGA cores in GFP channel; DiI-labeled cell membranes in RFP channel. Scale bar: 20 μm.g, Merged images from (f). Cy5 and GFP channels (left); GFP and RFP channels (center); all three channels (right). Scale bar: 20 μm. In panels c, f, and g, independent experiments were performed (n = 3) with similar results.
a-f, Comparison of the speed of bare algae (a,b) and algae-NP-robot (d,e) in simulated lung fluid (SLF) at room (22 °C), body (37 °C), and elevated body (40 °C) temperatures (blue, red, and green bars, respectively) (n = 6; mean ± s.d.). Optical tracking trajectories of the motion of bare algae (c) and algae-NP-robot (f) in SLF at 37 °C over 1 s (obtained at 0, 15, and 60 min: red, yellow, and orange, respectively) (Supplementary Movie 1).g-l, Representative trajectories (g, i, and k) from Supplementary Movie 2 corresponding to 0 s, 1 s, and 2 s, respectively, and mean speed distribution (h, j, and l) of algae-NP-robot in SLF at 37 °C after 0 min (g and h), 15 min (i and j), and 60 min (k and l). Scale bar: 50 μm.
a,Ex vivo fluorescent imaging of lungs at various timepoints after intratracheal administration with tris-acetate-phosphate (TAP) medium, algae-NP-robot, or static algae-NP as a negative control (H, high signal; L, low signal).b, Normalized intensity per gram of tissue of lung samples collected in (a) (n = 3; mean + s.d.).c, Brightfield and fluorescence microscopy images of representative algae-NP-robot incubated with macrophages at various stages of their interaction. Scale bar = 10 μm. Independent experiments (n = 3) were performed with similar results.d, Macrophage phagocytosis of static algae-NP or algae-NP-robot over time (n = 3; mean + s.d.).e, Relative fluorescence intensity of algae-NP-robot or static algae-NP over time after incubation with macrophage cellsin vitro (n = 3; mean + s.d.).f, Representative flow cytometry dot plots of algae-NP-robot (left) and static algae-NP (right) uptake by alveolar macrophages (CD11c+ Siglec-F+) at various timepoints after intratracheal administrationin vivo.g, Comparison of algae-NP-robot and static algae-NP uptake in alveolar macrophages at various timepoints after intratracheal administrationin vivo (n = 3; mean + s.d.).
a, Quantification of ciprofloxacin (Cip) loading on different numbers of algae (n = 6; mean + s.d.).b, The cumulative drug release profile of NP(Cip) and algae-NP(Cip)-robot (n = 3; mean + s.d.).c, Optical density at 600 nm (OD600) measurements ofP. aeruginosa treated with control TAP buffer, free Cip, NP(Cip), static algae-NP(Cip), and algae-NP(Cip)-robot (n = 3; mean + s.d.).d,In vitro antibacterial activity of free Cip, NP(Cip), static algae-NP(Cip), and algae-NP(Cip)-robot againstP. aeruginosa (n = 3; geometric mean + s.d.).e,f,In vivo antibacterial efficacy of control TAP buffer, NP(Cip), static algae-NP(Cip), and algae-NP(Cip)-robot with a dosage of 500 ng by intratracheal administration and free Cip with the same dosage of 500 ng as used in intratracheal administration and clinical dosage of 1.64 mg by intravenous (IV) administration inP. aeruginosa-infected mice, as determined by bacterial enumeration (e, n = 6; geometric mean +_s.d.) and survival (g, n = 12 per group) studies.g. Quantification of bacterial load in the lungs at 24 h, 48 h, 72 h, and 168 h after the algae-NP(Cip)-robot treatment (n = 6; geometric mean + s.d.). UD: undetectable.h,i, Experimental timeline (h) and data (i) for the enumeration of the bacterial load in the lungs of mice treated with algae-NP(Cip)-robot at different times after challenge withP. aeruginosa (n = 6; geometric mean + s.d.). one-way ANOVA fore,g, andi and log-rank (Mantel-Cox) test forf.
a, Comprehensive blood chemistry panel taken 24 h after intratracheal administration of TAP buffer or 24 h, 72 h, and 168 h after that of algae-NP(Cip)-robot (n = 3; mean + s.d.). ALB: albumin; ALP: alkaline phosphatase; ALT: alanine transaminase; AMY: amylase; TBIL: total bilirubin; BUN: blood urea nitrogen; CA: calcium; PHOS: phosphorus; CRE: creatinine; GLU: glucose; NA+: sodium; K+: potassium; TP: total protein; GLOB: globulin.b, Counts of various blood cells 24 h after intratracheal administration of TAP buffer or 24 h, 72 h, and 168 h after that of algae-NP(Cip)-robot (n = 3; geometric mean + s.d.). WBC: white blood cells; RBC: red blood cells; PLT: platelets.c-e, Hematoxylin and eosin staining of histology sections from major organs 24 h (c), 72 h (d), and 168 h (e) after intratracheal administration of TAP buffer or algae-NP(Cip)-robot. Scale bar: 250 μm. Independent experiments (n = 3) were performed with similar results.f-h, Cytokines, including TNF-α (f), IL-1β (g), IL-6 (h), measured in bronchoalveolar lavage fluid from healthy control mice or 24 h, 72 h, and 168 h after intratracheal administration of algae-NP(Cip)-robot. (n = 3; mean ± s.d.)i, Representative images of H&E staining on lung histology sections taken from healthy control mice or 24 h, 72 h, and 168 h after intratracheal administration of algae-NP(Cip)-robot. Scale bar: 100 μm. Independent experiments were performed (n = 3) with similar results.
Similar articles
- Acute exposure to silica nanoparticles enhances mortality and increases lung permeability in a mouse model of Pseudomonas aeruginosa pneumonia.Delaval M, Boland S, Solhonne B, Nicola MA, Mornet S, Baeza-Squiban A, Sallenave JM, Garcia-Verdugo I.Delaval M, et al.Part Fibre Toxicol. 2015 Jan 21;12(1):1. doi: 10.1186/s12989-014-0078-9.Part Fibre Toxicol. 2015.PMID:25605549Free PMC article.
- Sugar administration is an effective adjunctive therapy in the treatment of Pseudomonas aeruginosa pneumonia.Bucior I, Abbott J, Song Y, Matthay MA, Engel JN.Bucior I, et al.Am J Physiol Lung Cell Mol Physiol. 2013 Sep;305(5):L352-63. doi: 10.1152/ajplung.00387.2012. Epub 2013 Jun 21.Am J Physiol Lung Cell Mol Physiol. 2013.PMID:23792737Free PMC article.
- Targeted delivery of antibiotics to the infected pulmonary tissues using ROS-responsive nanoparticles.Wang Y, Yuan Q, Feng W, Pu W, Ding J, Zhang H, Li X, Yang B, Dai Q, Cheng L, Wang J, Sun F, Zhang D.Wang Y, et al.J Nanobiotechnology. 2019 Oct 3;17(1):103. doi: 10.1186/s12951-019-0537-4.J Nanobiotechnology. 2019.PMID:31581948Free PMC article.
- Recent advances in the treatment of Pseudomonas aeruginosa infections in cystic fibrosis.Høiby N.Høiby N.BMC Med. 2011 Apr 4;9:32. doi: 10.1186/1741-7015-9-32.BMC Med. 2011.PMID:21463524Free PMC article.Review.
- Colistin- and amikacin-loaded lipid-based drug delivery systems for resistant gram-negative lung and wound bacterial infections.Vairo C, Villar Vidal M, Maria Hernandez R, Igartua M, Villullas S.Vairo C, et al.Int J Pharm. 2023 Mar 25;635:122739. doi: 10.1016/j.ijpharm.2023.122739. Epub 2023 Feb 17.Int J Pharm. 2023.PMID:36801363Review.
Cited by
- Cell-derived biomimetic nanoparticles for the targeted therapy of ALI/ARDS.Gao R, Lin P, Fang Z, Yang W, Gao W, Wang F, Pan X, Yu W.Gao R, et al.Drug Deliv Transl Res. 2024 Jun;14(6):1432-1457. doi: 10.1007/s13346-023-01494-6. Epub 2023 Dec 20.Drug Deliv Transl Res. 2024.PMID:38117405Review.
- Macrophage-Based Microrobots for Anticancer Therapy: Recent Progress and Future Perspectives.Nguyen VD, Park JO, Choi E.Nguyen VD, et al.Biomimetics (Basel). 2023 Nov 18;8(7):553. doi: 10.3390/biomimetics8070553.Biomimetics (Basel). 2023.PMID:37999194Free PMC article.Review.
- Development and Characterization of Innovative Multidrug Nanoformulation for Cardiac Therapy.Gendron A, Domenichini S, Zanna S, Gobeaux F, Piesse C, Desmaële D, Varna M.Gendron A, et al.Materials (Basel). 2023 Feb 22;16(5):1812. doi: 10.3390/ma16051812.Materials (Basel). 2023.PMID:36902927Free PMC article.
- Swarming magnetic nanorobots bio-interfaced by heparinoid-polymer brushes for in vivo safe synergistic thrombolysis.Yang M, Zhang Y, Mou F, Cao C, Yu L, Li Z, Guan J.Yang M, et al.Sci Adv. 2023 Dec;9(48):eadk7251. doi: 10.1126/sciadv.adk7251. Epub 2023 Nov 29.Sci Adv. 2023.PMID:38019908Free PMC article.
- Extremophile-based biohybrid micromotors for biomedical operations in harsh acidic environments.Zhang F, Li Z, Duan Y, Luan H, Yin L, Guo Z, Chen C, Xu M, Gao W, Fang RH, Zhang L, Wang J.Zhang F, et al.Sci Adv. 2022 Dec 23;8(51):eade6455. doi: 10.1126/sciadv.ade6455. Epub 2022 Dec 23.Sci Adv. 2022.PMID:36563149Free PMC article.